Back

Salarius Announces Pricing of $5.3 Million Underwritten Public Offering

Read More

Back

Salarius Announces Proposed Public Offering of Common Stock

Read More

Back

Salarius Pharmaceuticals to Expand Clinical Program to Target Additional Sarcomas in Ewing Sarcoma Phase 1/2 Clinical Trial

Read More

Back

Salarius Pharmaceuticals Announces Move to New Corporate Offices at Texas Medical Center

Read More

Back

Salarius Pharmaceuticals Names Nadeem Mirza, M.D., M.P.H., as Senior Vice President Clinical Development

Read More